SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings
- PMID: 12451209
- DOI: 10.1212/01.wnl.0000035625.19871.dc
SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings
Abstract
The authors describe an Alberta family with levodopa-responsive parkinsonism without cerebellar abnormalities. Genetic testing showed expanded repeats for SCA-2; other mutations for parkinsonism were excluded. The expanded allele shows interruption of the CAG repeat with CAA. PET in two affected members showed reduced fluorodopa uptake in striatum and normal raclopride binding. Families with autosomal dominant, levodopa-responsive parkinsonism should be tested for the SCA-2 mutation.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials